Page 55 - GTM-3-3
P. 55

Global Translational Medicine                                            COVID-19 and acute kidney injury



            developed acute kidney injury (AKI) despite having   included. Studies focusing on severe acute respiratory
            normal creatinine levels. 2                        syndrome (SARS) and Middle East respiratory syndrome
              While the severe acute respiratory syndrome coronavirus   (MERS) but not COVID-19 were excluded.
            2 (SARS-CoV-2) primarily affects the respiratory system,   2.3. Data collection
            clinical findings from several deceased cases suggest that
            other organs may also be involved.  Given the limited   For each eligible study, the following information was
                                          2
            information on kidney disease in COVID-19 patients, this   recorded: first authors, study site, inclusion and exclusion
            meta-analysis aims to determine the incidence of AKI in   criteria,  sample  size,  age,  and  sex  of  participants.
            COVID-19 patients by pooling available published data. In   A  standardized data entry form was developed to focus
            addition, we evaluated the association between markers of   on the following areas: the total number of patients, the
            abnormal kidney function and mortality in these patients.   number of AKI patients, AKI-related indicators, according
            Despite ongoing research, specific treatments for COVID-  to AKI Network: (i) an increase in serum creatinine level
            19-related  kidney  complications  remain  elusive.  This   of ≥0.3 mg/dL, (ii) an increase in baseline serum creatinine
            review also explores potential pathogenic mechanisms to   level to ≥150%), and AKI-related death (Tables 2 and 3).
            inform future therapeutic interventions.           2.4. Data synthesis and statistical analysis

            2. Data and methods                                The primary outcomes of our study included the incidence
                                                               of AKI in COVID-19-infected patients (Table 4), mortality
            2.1. Literature search                             in patients who developed AKI (Table 5), clinical
            We conducted a systematic review of the literature on   symptoms, and markers of kidney injury.
            COVID-19 and its association with AKI. The systematic   For the AKI prevalence rates, data were pooled and
            review was performed in accordance with the Preferred   analyzed using SPSS and MedCalc. When two or more
            Reporting  Items for  Systematic  Reviews  and  Meta-  studies with at least four patients reported the same
            Analyses (PRISMA) guidelines. 3                    outcome under the same definition, a random effects
              Two authors independently performed a literature   model was used. Double arcsine transformation was
            search using PubMed, Web of Science, Embase, and the   applied to pool the proportions. The results were presented
            Cochrane Library. The search followed pre-specified   using forest plots (Figure 1A and B), which illustrate the
            criteria to include studies reporting clinic characteristics,   prevalence, 95% confidence intervals, and weightings.
            AKI incidence, mortality rates, and the risk of death   Cochran’s Q test was used to detect heterogeneity, with a
                                                                                                      2
            associated with AKI during COVID-19 infection. The data   P <0.10 indicating significant heterogeneity. The I  statistic
            were pooled for statistical analysis using MedCalc software   was calculated to measure the proportion of total variation
            to derive conclusions. 4                           in study estimates attributable to heterogeneity, with  I 2
                                                               >50% suggesting substantial heterogeneity.
              A comprehensive literature search was performed
            using both MeSH terms and free-text keywords, including   3. Results
            “COVID-19”/“SARS-CoV-2,” “AKI”/“acute kidney injury,”
            and “English language.” The databases searched included   3.1. Literature search and study selection
            PubMed, Embase, Cochrane Library, Cochrane COVID-  The PRISMA flow  diagram (Figure  2) outlines the study
            19 Study Register, Directory of Open Access Journals, and   selection process. Initially, 1723 records were identified, with
            Web of Science, covering publications up to June 8, 2023.   an additional 11 records obtained from reference lists. After
            The search strategy is presented in  Table 1. Additional   removing duplicates, 1535 records remained for screening. 2,5-7
            relevant articles were identified by reviewing the reference
            lists of the included studies.                     3.2. Characteristics of included studies
                                                               Table 2 summarizes the basic characteristics of the four
            2.2. Selection criteria                            studies included in the qualitative analysis, focusing on
            All articles identified through the literature search were   serum creatinine markers. 2,5,7,8  In addition, Table 6 presents
            screened by two independent reviewers (M.S.S and R.J).   the Newcastle-Ottawa scores for the included studies.
            We included studies on COVID-19 in adult patients. Full
            articles, conference abstracts, case reports, case series, non-  3.3. Publication bias
            randomized studies, randomized trials, and observational   Publication bias was assessed using funnel plot analysis
            studies published in English were included in this review.   (Figure 3), which indicated no evidence of bias among the
            Commentaries, letters to editors, and editorials were also   included studies. 2,5-8



            Volume 3 Issue 3 (2024)                         2                               doi: 10.36922/gtm.2798
   50   51   52   53   54   55   56   57   58   59   60